Detalles de la búsqueda
1.
Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine.
Int J Infect Dis
; 146: 107108, 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795841
2.
Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial.
Haematologica
; 98(11): 1726-31, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23753028
3.
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies.
Clin Microbiol Infect
; 28(6): 885.e7-885.e11, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35259530
4.
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation.
Leuk Lymphoma
; 62(9): 2161-2168, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33764240
5.
Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma.
Eur Radiol
; 20(8): 2027-38, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20309558
6.
Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma.
Haematologica
; 92(6): 778-83, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17550850
Resultados
1 -
6
de 6
1
Próxima >
>>